Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice

Leukemia Research

Volumn 28, Issue 7, 2004, Pages 763-769

  Ruan, Guo Rui ^a   Liu, Yan Rong ^a   Chen, Shan Shan ^a   Fu, Jia Yu ^a   Chang, Yan ^a   Qin, Ya Zhen ^a   Li, Jin Lan ^a   Yu, Hong ^a   Wang, Hui ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

basic fibroblast growth factor; bFGF; BMEC; bone marrow endothelial cell; chronic myeloid leukemia; CML; EGF; endothelial growth factor; microvessel density; MVD; UEA 1; vascular endothelial growth factor; VEGF; von Willebrand factor; vWF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA INTERFERON; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE; IMATINIB; LIPOCORTIN 5; PROPIDIUM IODIDE; STI 1571; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; BIOASSAY; CANCER GROWTH; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL GROWTH; CELL LABELING; CELL PROLIFERATION; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MICROVASCULATURE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SECRETION; STAINING; SUPERNATANT; TUMOR;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL DIVISION; DNA, ANTISENSE; DNA, COMPLEMENTARY; HUMANS; INTERFERON-ALPHA; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 2442517389     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.11.017     Document Type: Article

References (31)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 285:1972;1182-1186
2. Mangi M.H. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol. 111:2000;43-51
3. Michael K., Patricia A.D. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7(3):1996;259-270
4. Gerhard S., Georg M-B., Dieter M. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev. 17:1998;241-248
5. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82(1):1990;4-6
6. Folkman J., Cole P., Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastasis of biopsy material in rabbit thyroid and canine intestinal segment. Ann. Surg. 164:1996;491-502
7. Srivastava A., Laidler P., Davies R.P., Hughes L. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am. J. Pathol. 133:1988;419-423
8. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8
9. Aguayo A., Kantarjian H., Talpaz M., Estey E., Koller C., Estrov Z., et al. Increased angiogenesis in chronic leukemia and myelodysplastic syndromes. Blood. 92(10, Suppl. 1):1998;607a
10. Fumiatti R., Soligo D., Venegoni L., Deliliers G.L. Bone marrow angiogenesis is increased in CML in chronic and blastic phase, but is completely reversed by bone marrow transplantation. Blood. 96(11):2000;254b
11. Francesco D.R., Epifanio F., Maria P.A., Raimondo F.D., Fichera E., Azzaro M.P., et al. Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients. Blood. 96(11):2000;253b
12. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 96(6):2000;2240-2245
13. Guo-Rui R., Yan-Rong L., Shan-Shan C., Jin-Lan L., Ya-Zhen Q., Jia-Yu F., et al. Expression of vascular endothelial growth factor in the bone marrow cells from adult chronic myelogenous leukemia. J Exp Hematol. 9(1):2001;5-9
14. Pruneri G., Bertolini F., Soligo D., Carboni N., Cortelezzi A., Ferrucci D.F., et al. Angiogenesis in myelodysplastic syndromes. Br. J. Cancer. 81:1999;1398-1401
15. Perez-Atayde A.R., Sallan S.E., Tedrow U., Connors S., Allred E., Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am. J. Pathol. 150(3):1997;815-821
16. Veiga J.P., Afonso H., Sallan S.E., Nadler L.M., Cardoso A.A. Acute lymphoblastic leukemia cells and their bone marrow stroma collaborate to induce endothelial cell proliferation thereby promoting leukemia cell survival. Blood. 92(10, suppl 1):1998;511a
17. Fiedler W., Graeven U., Ergun S., Verago S., Kilic N., StockschlAder M., et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood. 89(6):1997;1870-1875
18. Padro T., Ruiz S., Bieker R., Burger H., Steins M., Kienast J., et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 95(8):2000;2637-2644
19. Hussong J.W., Rodgers G.M., Shami P.J. Evidence of increased angiogenesis on patients with acute myeloid leukemia. Blood. 95(1):2000;309-313
20. Shami P.J., Hussong J.W., Rodgers G.M. Evidence of increased angiogenesis in the bone marrow of patients with acute nonlymphocytic leukemia. Blood. 92(10, suppl 1):1998;512a
21. Chen H., Treweeke A.T., West D.C., Till K.J., Cawley J.C., Zuzel M., et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells. Blood. 96(9):2000;3181-3187
22. Kini A.R., Kay N.E., Peterson L.C. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia. 14(8):2000;1414-1418
23. Fusetti L., Pruneri G., Gobbi A., Rabascio C., Carboni N., Peccatori F., et al. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production. Cancer Res. 60:2000;2527-2534
24. Bellamy W.T., Richter L., Frutiger Y., Grogan T.M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 59:1999;728-733
25. Lunin S., Kantarjian H., Manshouri T., Verstovsek S., Talpaz M., Faderl S., et al. Clinical relevance of Flk/KDR (VEGF-R2) and VEGF R1 proteins in chronic myelogenous leukemia (CML). Blood. 96(11):2000;350a
26. Rimsza L., Ahrens K., Mainwaring M., Bradshaw K., Trice T., Kao K.J., et al. Both freshly isolated hematologic tumor cells and cell lines stimulate endothelial growth: this effect correlates with VEGF levels only in the cell lines. Blood. 96(11):2000;60b
27. Bertolini F., Mancuso P., Alberto G., Pruneri G. The thin red line: angiogenesis in normal and malignant hematopoiesis. Exp Hematol. 28:2000;993-1000
28. Dias S., Hattori K., Zhu Z., Heissig B., Choy M., Lane W., et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. J. Clin. Invest. 106(4):2000;511-521
29. Thiesing J.T., Ohno-Jones S., Kolibaba K.S., Druker B.J. Efficacy of STI571, an Abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against Bcr-Abl-positive cells. Blood. 96(9):2000;3195-3199
30. Kuramoto K., Uesaka T., Kimura A., Kobayashi M., Watanabe H., Katoh O. ZK7, a novel zinc finger gene, is induced by vascular endothelial growth factor and inhibits apoptotic death in hematopoietic cells. Cancer Res. 60(2):2000;425-430
31. Ebos J.M.L., Tran J., Master Z., Dumont D., Melo J.V., Buchdunger E., et al. Imatinib mesylate (STI571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol Cancer Res. 1:2002;89-95